C7R-GD2.CART Cells for Patients With Relapsed or Refractory Neuroblastoma and Other GD2 Positive Cancers (GAIL-N)

NCT03635632 · clinicaltrials.gov ↗

PHASE1

Phase

ACTIVE_NOT_RECRUITING

Status

94

Enrollment

OTHER

Sponsor class

Conditions

Relapsed Neuroblastoma
Refractory Neuroblastoma
Relapsed Osteosarcoma
Relapsed Ewing Sarcoma
Relapsed Rhabdomyosarcoma
Uveal Melanoma
Phyllodes Breast Tumor

Interventions

GENETIC: C7R-GD2.CART cells

Sponsor

Baylor College of Medicine

Collaborators

[object Object]
[object Object]
[object Object]